Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation regarding potential securities fraud or unlawful business practices by the company and its officers [1][3] - Neogen's fourth quarter fiscal 2025 results indicated a decline in EBITDA margin to the high-teens percentage, down from 22% in the previous quarter, attributed to elevated inventory write-offs [3] Company Performance - Neogen's stock price experienced a significant drop of $1.04 per share, or 17.3%, closing at $4.96 per share following the announcement of its financial results [3] Legal Context - The Pomerantz Firm is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [4]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Neogen Corporation – NEOG